CDH2 and neoplasm: Wang et al. reported that overexpression of CASC2 resulted in downregulation of N-cadherin and Vimentin in GB cell lines, accompanied with tumor growth inhibition in vivo; whereas, silencing of CASC2 exerted the opposite effect (Wang et al. 2020).